149 related articles for article (PubMed ID: 35405309)
1. Overexpressed or hyperactivated Rac1 as a target to treat hepatocellular carcinoma.
Sauzeau V; Beignet J; Vergoten G; Bailly C
Pharmacol Res; 2022 May; 179():106220. PubMed ID: 35405309
[TBL] [Abstract][Full Text] [Related]
2. Regulatory mechanisms and therapeutic targeting of vasculogenic mimicry in hepatocellular carcinoma.
Zheng N; Zhang S; Wu W; Zhang N; Wang J
Pharmacol Res; 2021 Apr; 166():105507. PubMed ID: 33610718
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatic analysis of RHO family of GTPases identifies RAC1 pharmacological inhibition as a new therapeutic strategy for hepatocellular carcinoma.
Bayo J; Fiore EJ; Dominguez LM; Cantero MJ; Ciarlantini MS; Malvicini M; Atorrasagasti C; Garcia MG; Rossi M; Cavasotto C; Martinez E; Comin J; Mazzolini GD
Gut; 2021 Jul; 70(7):1362-1374. PubMed ID: 33106353
[TBL] [Abstract][Full Text] [Related]
4. Blockade of ARHGAP11A reverses malignant progress via inactivating Rac1B in hepatocellular carcinoma.
Dai B; Zhang X; Shang R; Wang J; Yang X; Zhang H; Liu Q; Wang D; Wang L; Dou K
Cell Commun Signal; 2018 Dec; 16(1):99. PubMed ID: 30545369
[TBL] [Abstract][Full Text] [Related]
5. miR-365 regulates liver cancer stem cells via RAC1 pathway.
Jiang ZB; Ma BQ; Liu SG; Li J; Yang GM; Hou YB; Si RH; Gao P; Yan HT
Mol Carcinog; 2019 Jan; 58(1):55-65. PubMed ID: 30182377
[TBL] [Abstract][Full Text] [Related]
6. SH3-domain binding protein 1 in the tumor microenvironment promotes hepatocellular carcinoma metastasis through WAVE2 pathway.
Tao Y; Hu K; Tan F; Zhang S; Zhou M; Luo J; Wang Z
Oncotarget; 2016 Apr; 7(14):18356-70. PubMed ID: 26933917
[TBL] [Abstract][Full Text] [Related]
7. T-box transcription factor 19 promotes hepatocellular carcinoma metastasis through upregulating EGFR and RAC1.
Ji X; Chen X; Zhang B; Xie M; Zhang T; Luo X; Liu D; Feng Y; Wang Y; Sun M; Li C; Huang W; Xia L
Oncogene; 2022 Apr; 41(15):2225-2238. PubMed ID: 35217793
[TBL] [Abstract][Full Text] [Related]
8. Identification of Fasudil as a collaborator to promote the anti-tumor effect of lenvatinib in hepatocellular carcinoma by inhibiting GLI2-mediated hedgehog signaling pathway.
Huang Y; Wang S; Zhang X; Yang C; Wang S; Cheng H; Ke A; Gao C; Guo K
Pharmacol Res; 2024 Feb; 200():107082. PubMed ID: 38280440
[TBL] [Abstract][Full Text] [Related]
9. An oral 2-hydroxypropyl-β-cyclodextrin-loaded spirooxindole-pyrrolizidine derivative restores p53 activity via targeting MDM2 and JNK1/2 in hepatocellular carcinoma.
Gao X; Wei M; Shan W; Liu Q; Gao J; Liu Y; Zhu S; Yao H
Pharmacol Res; 2019 Oct; 148():104400. PubMed ID: 31425749
[TBL] [Abstract][Full Text] [Related]
10. Tigecycline causes loss of cell viability mediated by mitochondrial OXPHOS and RAC1 in hepatocellular carcinoma cells.
Koch DT; Yu H; Beirith I; Schirren M; Drefs M; Liu Y; Knoblauch M; Koliogiannis D; Sheng W; De Toni EN; Bazhin AV; Renz BW; Guba MO; Werner J; Ilmer M
J Transl Med; 2023 Dec; 21(1):876. PubMed ID: 38041179
[TBL] [Abstract][Full Text] [Related]
11. Rac1 as a therapeutic anticancer target: Promises and limitations.
Bailly C; Beignet J; Loirand G; Sauzeau V
Biochem Pharmacol; 2022 Sep; 203():115180. PubMed ID: 35853497
[TBL] [Abstract][Full Text] [Related]
12. Human tumor necrosis factor (TNF)-alpha-induced protein 8-like 2 suppresses hepatocellular carcinoma metastasis through inhibiting Rac1.
Cao X; Zhang L; Shi Y; Sun Y; Dai S; Guo C; Zhu F; Wang Q; Wang J; Wang X; Chen YH; Zhang L
Mol Cancer; 2013 Nov; 12(1):149. PubMed ID: 24274578
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of microRNA-100 enhances the ICMT-Rac1 signaling and promotes metastasis of hepatocellular carcinoma cells.
Zhou HC; Fang JH; Luo X; Zhang L; Yang J; Zhang C; Zhuang SM
Oncotarget; 2014 Dec; 5(23):12177-88. PubMed ID: 25361001
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA SchLAH suppresses metastasis of hepatocellular carcinoma through interacting with fused in sarcoma.
Ge Z; Cheng Z; Yang X; Huo X; Wang N; Wang H; Wang C; Gu D; Zhao F; Yao M; Fan J; Qin W
Cancer Sci; 2017 Apr; 108(4):653-662. PubMed ID: 28196303
[TBL] [Abstract][Full Text] [Related]
15. The NKD1/Rac1 feedback loop regulates the invasion and migration ability of hepatocarcinoma cells.
Li J; Zhang S; Hu Q; Zhang K; Jin J; Zheng X; Yin Z; Wang X
Sci Rep; 2016 May; 6():26971. PubMed ID: 27231134
[TBL] [Abstract][Full Text] [Related]
16. A novel KLF6-Rho GTPase axis regulates hepatocellular carcinoma cell migration and dissemination.
Ahronian LG; Zhu LJ; Chen YW; Chu HC; Klimstra DS; Lewis BC
Oncogene; 2016 Sep; 35(35):4653-62. PubMed ID: 26876204
[TBL] [Abstract][Full Text] [Related]
17. The combination effects of Shen-Ling-Bai-Zhu on promoting apoptosis of transplanted H22 hepatocellular carcinoma in mice receiving chemotherapy.
Xi S; Peng Y; Minuk GY; Shi M; Fu B; Yang J; Li Q; Gong Y; Yue L; Li L; Guo J; Peng Y; Wang Y
J Ethnopharmacol; 2016 Aug; 190():1-12. PubMed ID: 27235019
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of BDNF suppressed invasion of HepG2 and HCCLM3 cells, a mechanism associated with inactivation of RhoA or Rac1 and actin skeleton disorganization.
Guo D; Sun W; Zhu L; Zhang H; Hou X; Liang J; Jiang X; Liu C
APMIS; 2012 Jun; 120(6):469-76. PubMed ID: 22583359
[TBL] [Abstract][Full Text] [Related]
19. Romidepsin induces G2/M phase arrest via Erk/cdc25C/cdc2/cyclinB pathway and apoptosis induction through JNK/c-Jun/caspase3 pathway in hepatocellular carcinoma cells.
Sun WJ; Huang H; He B; Hu DH; Li PH; Yu YJ; Zhou XH; Lv Z; Zhou L; Hu TY; Yao ZC; Lu MD; Shen X; Zheng ZQ
Biochem Pharmacol; 2017 Mar; 127():90-100. PubMed ID: 28012958
[TBL] [Abstract][Full Text] [Related]
20. miR-194 inhibits liver cancer stem cell expansion by regulating RAC1 pathway.
Ran RZ; Chen J; Cui LJ; Lin XL; Fan MM; Cong ZZ; Zhang H; Tan WF; Zhang GQ; Zhang YJ
Exp Cell Res; 2019 May; 378(1):66-75. PubMed ID: 30844391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
